Post Categories
Meet the Xenobots, Living Robots That Can Reproduce
February 28, 2022
“Life finds a way.” Those were the prophetic words of Dr. Ian Malcolm in Steven Spielberg’s blockbuster Jurassic Park. Now, as researchers discover that…
Cancer Cure? 10-Year Leukemia Remission Reported with Personalized T-Cell Therapy
February 21, 2022
Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia…
Groundbreaking Pig Heart Transplant Saves Patient’s Life
February 16, 2022
Xenotransplantation, or the transplantation of non-human tissues or organs into a human recipient, has long been a controversial possibility in the medical field. After…
Is Immune System Memory Good or Bad News for COVID-19?
February 14, 2022
The COVID-19 pandemic has prompted a boom in immunology research. One research question is whether a previous infection with a common-cold coronavirus helps the…
A New Proteo-Genomic Map Shows How Genes Connect to a Variety of Diseases
February 7, 2022
Like the infamous Marauder’s Map in the Harry Potter novels, which revealed all the secrets of Hogwarts Castle, a recently published proteo-genomic map uncovers…
Sea Squirts and Missing Genes
February 2, 2022
It might seem odd to use a tiny sea creature to explore human genetics. However, as recently reported on Shamini Bundell’s Nature Podcast, marine…
Approved: First Drug to Boost Growth in Children With Dwarfism
January 31, 2022
The first drug to counter the genetic mutation that causes achondroplasia, the most common form of dwarfism, received accelerated FDA approval in November. BioMarin…
Collaborations Continue to Reveal the Potential of Understanding Protein Structure and Interactions
January 24, 2022
Proteins are a string of amino acids linked together in a specific sequence, with 20 possible amino acids coming into play. Each protein is…
A Novel Approach to a New mRNA-Based Lyme Disease Vaccine: Tick Saliva
January 17, 2022
Lyme disease is the most commonly reported tick-borne illness in the United States and the worldwide burden of Lyme disease has increased in recent…
Medicare: Rising Premiums and Novel AD Drugs
January 12, 2022
Medicare recently announced that its Part B outpatient premium will increase by $21.60 per month in 2022. The increase marks one of Medicare’s largest…
Moo vs. Flu: Seasonal Flu Antibody Therapy Produced in Cows
January 10, 2022
Humans have used cows in vaccine development dating back to 1770 and the origins of the smallpox vaccine. In more modern medicine, transgenic cows…
Could Spider Webs Teach Us About Complex Brain Systems?
December 20, 2021
Scientists have spent decades working to understand how spiders spin their impossibly detailed, symmetrical webs. Despite those years of research, scientists remain baffled as…
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
April 3, 2024
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…